Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

ABBOTINDIA's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.00000
forwardPE 31.33993
debtToEquity 4.54900
earningsGrowth 0.04200
revenueGrowth 0.06800
grossMargins 0.46409
operatingMargins 0.25794
trailingEps 717.27000
forwardEps 810.78674

Abbott India Limited's positive gross and operating margins indicate the company's ability to operate profitably. These margins reflect strong financial management, with efficient cost control contributing to sustained profitability and a solid financial outlook.
ABBOTINDIA's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that ABBOTINDIA's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

ABBOTINDIA's present price, in comparison to its projections, indicates no evident risks or opportunities. This balanced scenario suggests a steady environment, where investors might choose to wait for more definitive indicators before altering their strategies.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts' buy bias for ABBOTINDIA signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ABBOTINDIA, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.